INFU

SEC source: 0001014108-18-000209 · primary_doc.xml · nonDerivative · entry 2

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,428,861

F1 · ownership.nature: These securities are owned by Imua T Capital Investments, LLC. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-18-000203 · primary_doc.xml · nonDerivative · entry 2

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,419,313

F1 · ownership.nature: These securities are owned by Imua T Capital Investments, LLC. As described in Amendment No. 1 to Schedule 13D filing made on August 31, 2018, with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P., BlueLine Partners, L.L.C., Imua T Capital Investments, LLC, Imua T Capital Management, LP and Scott Shuda, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

F2 · ownership.nature: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-18-000203 · primary_doc.xml · nonDerivative · entry 1

Shuda Scott · CIK 0001486636 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,402,109

F1 · ownership.nature: These securities are owned by Imua T Capital Investments, LLC. As described in Amendment No. 1 to Schedule 13D filing made on August 31, 2018, with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P., BlueLine Partners, L.L.C., Imua T Capital Investments, LLC, Imua T Capital Management, LP and Scott Shuda, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

F2 · ownership.nature: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-18-000190 · primary_doc.xml · derivative · entry 1

Peele Ronald H. Jr. · CIK 0001747991 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2023-08-23

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning on September 23, 2018.

SEC source: 0001014108-18-000196 · primary_doc.xml · derivative · entry 1

Schulte Gregory · CIK 0001740199 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2023-08-23

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning on September 23, 2018.

SEC source: 0001014108-18-000192 · primary_doc.xml · derivative · entry 3

Shuda Scott · CIK 0001486636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2023-08-23

F2 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning on September 23, 2018.

SEC source: 0001014108-18-000194 · primary_doc.xml · derivative · entry 1

WHITTERS JOSEPH E · CIK 0001186680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2023-08-23

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning on September 23, 2018.

SEC source: 0001014108-18-000195 · primary_doc.xml · derivative · entry 2

Dilorio Richard · CIK 0001706994 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2023-08-23

F3 · derivative.exercise_date: The option, representing the right to purchase a total of 200,000 shares of InfuSystem Holdings, Inc. common stock, vests in three annual installments beginning on August 23, 2019.

SEC source: 0001014108-18-000195 · primary_doc.xml · derivative · entry 1

Dilorio Richard · CIK 0001706994 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2021-08-23

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These restricted stock units are eligible for vesting over a three-year period beginning August 23, 2018. The first 25,000 will vest if the company's closing stock price is above $4.00 for ten consecutive trading days prior to the one year anniversary of the grant. An additional 50,000 will vest if the company's closing stock price is above $5.00 for ten consecutive trading days prior to the two year anniversary of the grant. An additional 50,000 will vest if the company's closing stock price is above $6.00 for ten consecutive trading days prior to the three year anniversary of the grant.

SEC source: 0001014108-18-000193 · primary_doc.xml · derivative · entry 1

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2023-08-23

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning on September 23, 2018.

SEC source: 0001014108-18-000189 · primary_doc.xml · derivative · entry 1

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2023-08-23

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 35,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning on September 23, 2018.

SEC source: 0001014108-18-000191 · primary_doc.xml · derivative · entry 1

Montgomery Darrell B · CIK 0001639250 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2023-08-23

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning on September 23, 2018.

SEC source: 0001014108-18-000188 · primary_doc.xml · derivative · entry 1

Armstrong Terry L. · CIK 0001747880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2023-08-23

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning on September 23, 2018.

SEC source: 0001437749-18-016011 · rdgdoc.xml · nonDerivative · entry 2

Armstrong Terry L. · CIK 0001747880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

SEC source: 0001437749-18-016011 · rdgdoc.xml · nonDerivative · entry 1

Armstrong Terry L. · CIK 0001747880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,200

SEC source: 0001437749-18-016000 · rdgdoc.xml · nonDerivative · entry 1

Peele Ronald H. Jr. · CIK 0001747991 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

SEC source: 0001014108-18-000164 · primary_doc.xml · nonDerivative · entry 1

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,946

SEC source: 0001437749-19-002849 · rdgdoc.xml · nonDerivative · entry 1

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,946

F1 · shares: The shares were sold by a broker without reporting person's knowledge

SEC source: 0001014108-18-000163 · primary_doc.xml · nonDerivative · entry 1

DREYER DAVID C · CIK 0001203607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These shares were originally part of an order, the balance of which traded and were reported on Form 4 on June 14, 2018. The order was believed cancelled until the holder received another trade confirmation reporting the completion of the order on June 18, 2018.

SEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 5

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,346,834

F3 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 4

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,214,814

F2 · ownership.direct: These securities are owned by Meridian TSV II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-18-000162 · primary_doc.xml · nonDerivative · entry 1

DREYER DAVID C · CIK 0001203607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,719

SEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 3

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,199,814

F2 · ownership.direct: These securities are owned by Meridian TSV II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,189,814

F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,189,652

F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 4

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,184,652

F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001014108-18-000128 · primary_doc.xml · nonDerivative · entry 5

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 293,388

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-18-000128 · primary_doc.xml · nonDerivative · entry 3

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 1,396,264

F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 3

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,179,652

F2 · ownership.direct: These securities are owned by Meridian TSV II, LP.

SEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,178,811

F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001014108-18-000128 · primary_doc.xml · nonDerivative · entry 4

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 293,355

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-18-000128 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 1,396,097

F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-18-000124 · primary_doc.xml · nonDerivative · entry 5

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 293,238

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-18-000124 · primary_doc.xml · nonDerivative · entry 3

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 1,395,514

F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,177,867

F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

F3 · ownership.direct: The amount of securities beneficially owned by the Reporting Persons was incorrectly stated on the Form 4 filed on May 24, 2017 and was reflected in all subsequent reports but is being corrected with this Form 4 filing.

SEC source: 0001014108-18-000124 · primary_doc.xml · nonDerivative · entry 4

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 290,981

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-18-000124 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 1,384,229

F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-18-000121 · primary_doc.xml · nonDerivative · entry 4

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,635

F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P.

SEC source: 0001014108-18-000121 · primary_doc.xml · nonDerivative · entry 3

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,332,500

F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P.

SEC source: 0001445866-18-000545 · form4.xml · nonDerivative · entry 3

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,196,200

F2 · ownership.direct: These securities are owned by Meridian TSV II, LP.

SEC source: 0001445866-18-000545 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,194,145

F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001014108-18-000121 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,571

F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P.

SEC source: 0001014108-18-000121 · primary_doc.xml · nonDerivative · entry 1

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,317,178

F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P.

SEC source: 0001445866-18-000545 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · 10% owner

Meridian TSV II, LP · CIK 0001601536 · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,164,145

F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001014108-18-000119 · primary_doc.xml · derivative · entry 1

Schulte Gregory · CIK 0001740199 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2023-05-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 125,000 shares of InfuSystem Holdings, Inc. common stock, will vest over a four-year period, with 1/48th vesting on each monthly anniversary of the grant date, provided Mr. Schulte remains employed by the Company through such vesting dates.

SEC source: 0001445866-18-000266 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,155,652

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 5

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,115,652

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 4

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,095,652

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 3

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,071,652

F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,066,885

F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.